Search
for
Sort by
Research 31–60 of 775
- Efficacy of Baricitinib in Patients with Various Degrees of Alopecia Areata Severity: Post-Hoc Analysis from BRAVE AA1 and BRAVE AA2
- 44096 Efficacy in Subgroups related to Disease Characteristics in Patients with Alopecia Areata from BRAVE-AA1 and BRAVE-AA2
- Selective inhibition of JAK3 signaling is sufficient to reverse alopecia areata
- Treatment of moderate-to-severe alopecia areata in pre-adolescent children with baricitinib
- Baricitinib Demonstrates Rapid Action Within Just 2 Months of Treatment in Severe and Unresponsive Alopecia Areata: A Case Report
- Efficacy and safety of baricitinib in patients with alopecia areata: evidence to date
- Spotlight in Plastic Surgery: October 2022
- 33766 Efficacy of baricitinib in patients with various degrees of alopecia areata severity: Results from BRAVE-AA1 and BRAVE-AA2
- JAK Family Expression and Therapeutic Implications in Primary Cicatricial Alopecias
- An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch-Type Alopecia Areata, Totalis, and Universalis
- Pharmacological Treatment of Alopecia
- Alopecia Areata: Current Review
- JAK1 Signaling Is Involved in the Induction of Mechanical Alloknesis in Atopic Dermatitis
- A new era for alopecia areata: New treatments and improved knowledge of the condition
- Efficacy and safety of deuruxolitinib, an oral selective Janus kinase inhibitor, in adults with alopecia areata: Results from the Phase 3 randomized, controlled trial (THRIVE-AA1)
- Efficacy and Potential Mechanisms of Naringin in Atopic Dermatitis
- Epigallocatechin-3 Gallate Inhibits STAT-1/JAK2/IRF-1/HLA-DR/HLA-B and Reduces CD8 MKG2D Lymphocytes of Alopecia Areata Patients
- INVESTIGATING THE MECHANISMS UNDERLYING THE PATHOGENESIS OF ALOPECIA AREATA
- Could baricitinib treat frontal fibrosing alopecia and facial papules?
- Baricitinib as a treatment for myasthenia gravis: A case report
- Emerging Topical and Systemic JAK Inhibitors in Dermatology
- JAK-Inhibitors Beyond the Label: Emerging Applications in Dermatology
- Reversal of Alopecia Areata Following Treatment With the JAK1/2 Inhibitor Baricitinib
- JAK 1-3 inhibitors and TYK-2 inhibitors in dermatology: Practical pearls for the primary care physician
- Safety of Janus Kinase inhibitors in Patients with Alopecia Areata: A Systematic Review
- JAK inhibitors in dermatology: The promise of a new drug class
- Comparative Efficacy and Safety of Janus Kinase Inhibitors Used in Alopecia Areata: A Systematic Review and Meta-analysis
- Janus Kinase Inhibitors in the Treatment of Alopecia Areata
- JAK Inhibitors for Treatment of Alopecia Areata
- Alopecia Areata: Case report and review of pathophysiology and treatment with Jak inhibitors